Search

Abt is evaluating if new approaches to CMS’s Integrated Care for Kids (InCK) Model can improve outcomes for Medicaid-enrolled children while controlling costs.

Our toxicologists design, implement, conduct and manage a wide range of laboratory and field-based bioassays, investigations and other tests to fill key data gaps and increase our understanding of the adverse effects of chemicals, mixtures, and other stressors on numerous organisms, including bacteria, algae, invertebrates, fish, reptiles, birds, and mammals.

Abt teams with governments around the world to develop sustainable service delivery through better management of the public sector and public finance. Our systems- and evidence-based approaches—refined in partnership with government, service providers, and communities—facilitate mutual goals in public management. By fostering trade and investment-friendly environments, we help set the stage for sustainable economic growth. We increase transparency and accountability in public institutions by facilitating e-governance and digital platforms.

This brief summarizes expert interviewee observations on marijuana legalzation’s public health effects and notes how they align with other study findings.

Abt helped design the ZAPPA tool so New York City could evaluate the potential impacts of proposed environmental polices, down to the neighborhood level.

Abt’s evaluation of Medicare’s AIM found $381.5 million in savings, and raised questions about how those savings—and risks—are shared.

Abt has extensive experience investigating and addressing the complex effects of per- and polyfluoroalkyl substances (PFAS) in the environment and on human health.

The Abt-led USAID Local Health System Sustainability Project is helping Ukraine adopt telemedicine to connect people to healthcare during the war with Russia.

Abt is a proud sponsor of the 2024 Society of Toxicology Annual Meeting.